Beurs gesloten -
Nasdaq
22:00:03 31-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
27,41
USD
|
+3,92%
|
|
+2,97%
|
-2,42%
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
19.426
|
17.116
|
17.432
|
12.497
|
12.361
|
-
|
-
|
Bedrijfswaarde
1 |
23.181
|
22.089
|
22.814
|
18.155
|
18.138
|
18.400
|
18.207
|
K/w-verhouding
|
31,2
x
|
39
x
|
558
x
|
11,1
x
|
13
x
|
11,1
x
|
9,39
x
|
Dividendrendement
|
0,6%
|
1,71%
|
1,92%
|
2,85%
|
3,29%
|
3,56%
|
3,77%
|
Marktkapitalisatie/omzet
|
9,15
x
|
7,48
x
|
7,79
x
|
5,31
x
|
4,66
x
|
4,23
x
|
3,88
x
|
Bedrijfswaarde/omzet
|
10,9
x
|
9,65
x
|
10,2
x
|
7,71
x
|
6,84
x
|
6,3
x
|
5,71
x
|
Bedrijfswaarde/EBITDA
|
14,3
x
|
11,4
x
|
8,89
x
|
6,47
x
|
7,28
x
|
6,74
x
|
6,17
x
|
Bedrijfswaarde/FCF
|
11,4
x
|
12,5
x
|
10,2
x
|
6,7
x
|
19,2
x
|
14,7
x
|
12,3
x
|
FCF Yield
|
8,78%
|
8%
|
9,8%
|
14,9%
|
5,22%
|
6,81%
|
8,1%
|
Price to Book
|
3,07
x
|
2,36
x
|
2,52
x
|
1,66
x
|
1,53
x
|
0,99
x
|
0,83
x
|
Aantal aandelen (in duizenden)
|
388.132
|
429.511
|
441.104
|
444.886
|
450.981
|
-
|
-
|
Referentieprijs
2 |
50,05
|
39,85
|
39,52
|
28,09
|
27,41
|
27,41
|
27,41
|
Datum van publicatie
|
17-02-21
|
15-02-22
|
15-02-23
|
15-02-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
2.122
|
2.289
|
2.237
|
2.355
|
2.651
|
2.923
|
3.188
|
EBITDA
1 |
1.621
|
1.944
|
2.566
|
2.806
|
2.492
|
2.732
|
2.951
|
Bedrijfsresultaat (EBIT)
1 |
1.598
|
1.921
|
2.560
|
2.806
|
2.111
|
2.384
|
2.831
|
Operationele Marge
|
75,31%
|
83,92%
|
114,44%
|
119,14%
|
79,61%
|
81,58%
|
88,82%
|
Resultaat voor belastingen (EBT)
1 |
-
|
-
|
230
|
1.700
|
1.411
|
1.468
|
-
|
Nettowinst (verlies)
1 |
975
|
620
|
43
|
1.135
|
941,8
|
1.097
|
1.274
|
Nettomarge
|
45,95%
|
27,09%
|
1,92%
|
48,2%
|
35,52%
|
37,52%
|
39,97%
|
WPA
2 |
1,606
|
1,021
|
0,0708
|
2,530
|
2,105
|
2,475
|
2,920
|
Free Cash Flow
1 |
2.035
|
1.767
|
2.235
|
2.708
|
947
|
1.253
|
1.475
|
FCF-marge
|
95,88%
|
77,18%
|
99,92%
|
115%
|
35,72%
|
42,87%
|
46,27%
|
Kasstroomconversie (ebitda)
|
125,52%
|
90,88%
|
87,11%
|
96,51%
|
38%
|
45,86%
|
49,97%
|
Kasstroomconversie (nettowinst)
|
208,68%
|
284,94%
|
5.198,2%
|
238,6%
|
100,56%
|
114,25%
|
115,78%
|
Dividend per aandeel
2 |
0,3000
|
0,6800
|
0,7600
|
0,8000
|
0,9006
|
0,9760
|
1,033
|
Datum van publicatie
|
17-02-21
|
15-02-22
|
15-02-23
|
15-02-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Omzet
1 |
576
|
562
|
536
|
573
|
566
|
684
|
538
|
536,3
|
596
|
568
|
603,2
|
683
|
713,6
|
-
|
-
|
EBITDA
1 |
494
|
556
|
480
|
548
|
983
|
1.044
|
498
|
582,2
|
682
|
656
|
592
|
651,7
|
625,1
|
701
|
640
|
Bedrijfsresultaat (EBIT)
1 |
488
|
550
|
480
|
548
|
983
|
1.044
|
498
|
582,2
|
681,7
|
656
|
396,2
|
403,8
|
867,8
|
-
|
-
|
Operationele Marge
|
84,72%
|
97,86%
|
89,55%
|
95,64%
|
173,67%
|
152,63%
|
92,57%
|
108,56%
|
114,38%
|
115,49%
|
65,67%
|
59,12%
|
121,61%
|
-
|
-
|
Resultaat voor belastingen (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettowinst (verlies)
1 |
8
|
52
|
305
|
143
|
-456
|
-
|
-
|
-
|
494
|
5
|
56,9
|
35,53
|
816,6
|
-
|
-
|
Nettomarge
|
1,39%
|
9,25%
|
56,9%
|
24,96%
|
-80,57%
|
-
|
-
|
-
|
82,89%
|
0,88%
|
9,43%
|
5,2%
|
114,42%
|
-
|
-
|
WPA
2 |
0,0132
|
0,0857
|
0,5025
|
0,2360
|
-0,7512
|
-
|
-
|
-
|
1,100
|
0,0100
|
0,1300
|
0,0800
|
1,820
|
-
|
-
|
Dividend per aandeel
2 |
-
|
-
|
0,1900
|
0,1900
|
0,1900
|
0,2000
|
0,2000
|
0,2000
|
0,2000
|
0,2000
|
0,2100
|
0,2100
|
0,2079
|
-
|
-
|
Datum van publicatie
|
15-02-22
|
05-05-22
|
04-08-22
|
08-11-22
|
15-02-23
|
09-05-23
|
08-08-23
|
08-11-23
|
15-02-24
|
09-05-24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
3.755
|
4.973
|
5.381
|
5.658
|
5.777
|
6.039
|
5.845
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
2,316
x
|
2,558
x
|
2,097
x
|
2,016
x
|
2,318
x
|
2,211
x
|
1,98
x
|
Free Cash Flow
1 |
2.035
|
1.767
|
2.235
|
2.708
|
947
|
1.253
|
1.475
|
ROE (netto-inkomsten/eigen vermogen)
|
18,5%
|
17,5%
|
28,2%
|
43,5%
|
29,8%
|
24,5%
|
22,6%
|
ROA (netto-inkomsten/totale activa)
|
10,4%
|
10,5%
|
13%
|
15,9%
|
9,67%
|
9,71%
|
9,34%
|
Totale activa
1 |
9.359
|
5.884
|
330,2
|
7.130
|
9.743
|
11.291
|
13.645
|
Nettoactief per aandeel
2 |
16,30
|
16,90
|
15,70
|
16,90
|
17,90
|
27,70
|
33,00
|
Cashflow per aandeel
2 |
5,420
|
3,320
|
3,530
|
4,960
|
4,140
|
4,290
|
-
|
Capex
1 |
-
|
2.192
|
1.742
|
2.116
|
1.500
|
1.500
|
1.500
|
Capex/omzet
|
-
|
95,74%
|
77,86%
|
89,85%
|
56,57%
|
51,32%
|
47,06%
|
Datum van publicatie
|
17-02-21
|
15-02-22
|
15-02-23
|
15-02-24
|
-
|
-
|
-
|
Laatste slotkoers
27,41
USD Gemiddelde koersdoel
45,75
USD Spread / Gemiddelde doel +66,91% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -2,42% | 12,36 mld. | | +40,73% | 739 mld. | | +31,57% | 598 mld. | | -6,30% | 353 mld. | | +15,15% | 318 mld. | | +4,05% | 285 mld. | | +15,25% | 240 mld. | | +9,53% | 210 mld. | | -5,11% | 206 mld. | | +6,17% | 164 mld. |
Farmaceutische producten - Andere
|